Skip to main navigation Skip to search Skip to main content

Effects of mitral valve disease etiology on the outcomes of mechanical and biological valve replacement: retrospective cohort study

  • Chun Yu Chen
  • , Feng Cheng Chang
  • , Chia Pin Lin
  • , Yi Hsin Chan
  • , Victor Chien Chia Wu
  • , Yu Ting Cheng
  • , Pao Hsien Chu
  • , An Hsun Chou
  • , Chi Hsiao Yeh
  • , Shao Wei Chen
  • Chang Gung University
  • Chang Gung Memorial Hospital

Research output: Contribution to journalJournal Article peer-review

5 Scopus citations

Abstract

INTRODUCTION: The choice of an artificial mitral valve (MV) is a crucial clinical decision that affects the long-term survival and quality of life of patients. However, current guidelines recommend selecting MV based on patient age and life expectancy at the time of mitral valve replacement (MVR), without considering the etiology of MV disease. This study aimed to investigate whether MV disease etiology should be considered when choosing a valve for MVR and to evaluate the impact of MV disease etiology on long-term patient survival. METHODS: Using data (2002-2018) from Taiwan's National Health Insurance Research Database, the authors conducted a nationwide retrospective cohort study to compare the biological and mechanical valves in terms of all-cause mortality as the primary outcome. The inverse probability of the treatment weighting method was used to reduce the effects of the confounding factors. The following etiologies were assessed: infective endocarditis, rheumatic heart disease, ischemic mitral regurgitation, and degenerative mitral regurgitation. RESULTS: In patients aged below 70 years, it was observed that mechanical valves demonstrated an association with benefits compared to biological valves in the context of survival. In patients with infective endocarditis aged below 72 years, mechanical valves were associated with survival benefits, but not in those with stroke during hospitalization. These valves were also found to be linked with survival advantages for patients with rheumatic heart disease aged below 60 years and for those with degenerative mitral regurgitation aged below 72 years. However, no age-dependent effects of valve type on all-cause mortality were observed in patients with ischemic mitral regurgitation. CONCLUSION: The etiology of MV disease appears to be important in the selection of a suitable MV and determination of a cutoff age for mechanical and biological MVR.

Original languageEnglish
Pages (from-to)3495-3503
Number of pages9
JournalInternational journal of surgery (London, England)
Volume110
Issue number6
DOIs
StatePublished - 01 06 2024

Bibliographical note

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Humans
  • Retrospective Studies
  • Male
  • Female
  • Middle Aged
  • Aged
  • Heart Valve Prosthesis Implantation/adverse effects
  • Heart Valve Prosthesis/adverse effects
  • Taiwan/epidemiology
  • Mitral Valve/surgery
  • Adult
  • Heart Valve Diseases/surgery
  • Bioprosthesis
  • Mitral Valve Insufficiency/surgery
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Effects of mitral valve disease etiology on the outcomes of mechanical and biological valve replacement: retrospective cohort study'. Together they form a unique fingerprint.

Cite this